Strides Pharma Science Shares Drop On US Drug Regulator's Warning Letter
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
from NDTV Profit - Latest https://ift.tt/2GsIzEz
from NDTV Profit - Latest https://ift.tt/2GsIzEz
0 Response to "Strides Pharma Science Shares Drop On US Drug Regulator's Warning Letter"
Post a Comment